---
title: "Multi-Omics Data Integration (AI-Assisted)"
description: "AI-assisted multi-omics data integration service unifying genomics, transcriptomics, proteomics, and metabolomics data into reproducible research insights."
url: "https://www.cd-genomics.com/ai-assisted-multi-omics-data-integration.html"
---

# AI-Assisted Multi-Omics Data Integration Service

Analyzing each omics layer on its own can hide the signal that only becomes clear once layers are combined. A transcriptomic change that looks weak in isolation can line up with a matching protein shift, a metabolite change, or a regulatory element, once the layers are integrated properly.

We help you bring these layers together without losing the ability to trust the result. Our team combines your genomic, transcriptomic, epigenomic, proteomic, metabolomic, or microbiome data, or generates a missing layer through a qualified partner platform, into one AI-assisted integration model with explicit validation at every step.

Key outputs include an integrated multi-omics feature matrix, a cross-layer correlation network, integration model outputs, a pathway and network interpretation summary, and reproducible code and methods.

## Details

### Why one omics layer is rarely the full picture

A striking result in a single omics layer can be a useful lead. It rarely explains, on its own, whether the signal reflects real cross-layer biology or a technical artifact.

Before an integrated finding is reported, the research team needs to know whether other layers support it, which integration method fits the sample size and data coverage, and whether the result would survive an independent cohort.

We bring these questions into one review. AI-assisted methods help align, harmonize, and model features across layers at a scale manual comparison cannot match. Our scientists select the integration strategy, check for batch and leakage risk, and connect each remaining gap to a specific recommendation. If an existing layer cannot resolve the question, we can generate the missing layer through a qualified partner platform.

We help answer six practical questions:

- Do changes in one omics layer align with changes in another, or are they independent?
- Which integration strategy fits my sample size and missing-data pattern?
- Is a cross-layer correlation real biology, or a shared batch effect?
- Which additional layer would most reduce uncertainty in my current finding?
- How do I know an integrated result is not simply overfit to a small cohort?
- What can I report with confidence, and what still needs independent validation?

### How we support common multi-omics integration decisions

#### 1. Combine data you already have across two or more omics layers

**Your question:** I have genomic, transcriptomic, proteomic, or metabolomic data from the same project. How do I combine them into one model instead of analyzing each layer separately?

**Data and experiments:** Matched or partially matched sample matrices across two or more omics layers, submitted under the Data-to-Insight entry option.

**How AI helps:** AI-assisted integration methods, ranging from matrix factorization to network fusion to deep generative models, align features across layers and learn joint structure that single-layer analysis cannot see.

**What we deliver:** An integrated feature matrix, a cross-layer correlation network, and integration model outputs appropriate to the method selected.

**How to validate:** Nested cross-validation with feature selection confined to training folds, plus an independent cohort or hold-out set where sample size allows.

**Published evidence:** Baião et al. reviewed classical statistical and deep generative integration methods and the trade-offs between them, underscoring that method choice should follow the data structure rather than a default pipeline.

#### 2. Choose an integration strategy for a small or unevenly covered cohort

**Your question:** My cohort is small, and not every sample has data in every omics layer. Which integration approach still works?

**Data and experiments:** Cohorts with partial layer coverage, where some samples lack one or more omics layers.

**How AI helps:** Matrix factorization and related joint-decomposition methods tolerate missing coverage in one layer better than concatenation-based approaches. For very small cohorts, we favor unsupervised, hypothesis-generating integration over supervised classification.

**What we deliver:** A recommended integration strategy matched to your coverage pattern, plus the resulting integration model.

**How to validate:** Cluster or factor stability checks rather than predictive-performance claims, since small cohorts cannot reliably support supervised validation.

**Published evidence:** Vahabi and Michailidis reviewed unsupervised multi-omics integration methods and their relative tolerance for incomplete or unevenly sized omics layers.

#### 3. Tell whether a cross-omics signal is real biology or a shared batch effect

**Your question:** A transcript and a protein correlate across my samples. Is that real regulation, or do both simply share a batch or processing-date effect?

**Data and experiments:** Omics data layers together with batch, processing-date, and platform metadata for every sample.

**How AI helps:** Batch and platform effects are evaluated per omics layer before integration, and corrected only when confounding with the outcome variable can be ruled out; feature selection stays confined to training folds to avoid leakage-driven correlations.

**What we deliver:** A batch-assessed, leakage-checked integrated result with the batch evaluation documented as part of the report.

**How to validate:** Independent cohort or hold-out validation, following the DOME-style reporting standard for supervised machine learning in biology.

**Published evidence:** Yu et al. reviewed methods for assessing and mitigating batch effects in large-scale omics studies, and Walsh et al.'s DOME recommendations set out the validation reporting expected for supervised biological machine learning.

#### 4. Decide whether to add a missing omics layer to strengthen a single-layer finding

**Your question:** My transcriptomic biomarker candidate needs stronger support. Would adding proteomics or metabolomics data actually improve the result, or is the current signal already sufficient?

**Data and experiments:** Existing single-layer data plus a newly generated proteomics or metabolomics layer, submitted under a Hybrid entry option.

**How AI helps:** AutoML-style comparison across many model families quantifies whether the integrated, multi-layer model outperforms the best single-layer model on the same validation scheme, rather than assuming integration always helps.

**What we deliver:** A direct model-performance comparison between the single-layer and integrated result, so the decision to add a layer is evidence-based.

**How to validate:** Same nested cross-validation and, where available, the same hold-out set applied to both the single-layer and integrated models for a fair comparison.

**Published evidence:** Hong et al. compared 17 machine learning models on plasma proteomics, PTM, and metabolomics data; the integrated model (LightGBMXT, AUC 0.9727) outperformed the best single-omics model (CNNBiLSTM, proteomics only, AUC 0.9636), a direct, published example of what adding a layer can and cannot change.

### Choose the layer or method that answers the missing question

More data is not always better. We select the omics layer and integration method that can change the research conclusion.

| Service technology | Question it can answer | Common use |
|---|---|---|
| [Genomic data analysis](/genomic-data-analysis.html) | Does variant burden or structural context support the integrated finding? | Germline background, subtype support, variant confirmation |
| [Transcriptomic data analysis](/transcriptomic-data-analysis.html) | Which pathways or regulatory programs change alongside the other layers? | Mechanism, cross-layer correlation, regulatory inference |
| [Epigenomics data analysis](/epigenomics-data-analysis-service.html) | Which regulatory elements may explain a transcript-protein relationship? | Methylation-expression correlation, regulatory mapping |
| [Single-cell RNA sequencing](/single-cell-rna-sequencing-data-analysis-service.html) | Which cell state carries the integrated signal? | Cell-resolved multi-omics integration |
| [Metagenomic sequencing data analysis](/metagenomic-sequencing-data-analysis-service.html) | Does host omics data correlate with microbiome composition or function? | Host-microbiome interaction studies |
| [Multi-Omics Analysis](/multi-omics.html) | Do several molecular layers support the same integrated finding? | Cross-layer confirmation, broader integration scope |
| [Bioinformatics services](/bioinformatics-services.html) | Can existing multi-platform data be harmonized and compared reliably? | Data review, batch harmonization, reproducible reporting |

### Project entry options

- **Data-to-Insight:** You provide existing data across two or more omics layers; we harmonize, integrate, and interpret it.
- **Sample-to-Insight:** You provide biological samples; qualified partner platforms generate the requested omics data, which then flows into the same integration pipeline.
- **Hybrid (Layer Addition):** You already have data for one or more layers; we generate the missing layer needed to complete or strengthen the integration.

### See why every integrated result can be inspected, not just trusted

An integrated result is only useful when the validation behind it is easy to inspect. We evaluate batch and platform effects per layer, confine feature selection to training folds under nested cross-validation, document the imputation strategy for any missing data, and use an independent cohort or hold-out set where sample size allows.

We also test whether an integrated finding holds up when the integration method or scoring assumptions change, rather than reporting a single method's output as final.

### From separate omics files to an integrated, validated result

1. **Define the decision:** Clarify which omics layers are available, the project entry option, and what the integrated result needs to support.
2. **Review data coverage:** Assess sample overlap across layers, missing-data pattern, and batch or platform metadata.
3. **Select the integration strategy:** Choose correlation-based, matrix factorization, network-based, or deep generative/AutoML methods based on layer count, sample size, and coverage.
4. **Preprocess each layer:** Normalize, evaluate batch effects, and filter features separately per omics layer before integration.
5. **Integrate and model:** Align features across layers and fit the selected integration model with nested cross-validation.
6. **Interpret the result:** Map integrated features to pathways and networks, and document which layers drive the finding.
7. **Test stability:** Check whether the finding holds under different method choices or when uncertain data points are down-weighted.
8. **Deliver and recommend next steps:** Provide the integrated feature matrix, report, and code, with a specific recommendation for any layer or validation still needed.

### Deliverables

- Per-layer QC and preprocessing report
- Integrated multi-omics feature matrix and cross-layer correlation network
- Integration model outputs (factor scores, cluster assignments, or classification results, depending on strategy)
- Pathway and network interpretation summary
- Reproducible analysis code and environment files
- Methods-ready write-up describing the integration approach and validation strategy

Multi-omics integration results remain probabilistic. We do not guarantee that an integrated signature will replicate in an independent cohort or hold up as a clinical-grade predictor.

**For Research Use Only. Not for use in diagnostic or clinical procedures.**

## Demo

The report is designed for research review. It can include a model-performance comparison across single-layer and integrated models, a precision-recall or ROC-style comparison chart, and a cross-layer protein or feature interaction network with hub nodes highlighted. Evidence layers and comparison points are selected for the project.

## FAQ

### Do I need matched samples across every omics layer?

Matched samples give the strongest integrative signal, but many methods, particularly matrix factorization approaches, tolerate partial overlap where not every sample has data in every layer. We assess your cohort structure during project planning and recommend the strategy that fits your actual data coverage.

### How small a cohort can still support multi-omics integration?

There is no fixed minimum, but very small cohorts are generally better suited to unsupervised, hypothesis-generating integration rather than supervised classification, where overfitting risk rises sharply as feature count exceeds sample count.

### Which integration method will you use for my project?

We select the strategy, correlation-based, matrix factorization, network-based, or deep generative/AutoML, according to the number of omics layers, sample size, missing-data pattern, and whether the goal is exploratory or predictive.

### Can you integrate data I generated with a different sequencing or proteomics vendor?

Yes. Under the Data-to-Insight option we accept processed and raw data files from any platform, provided the file formats and accompanying metadata meet the requirements discussed with your project manager.

### How do you guard against false-positive findings from high-dimensional integration?

Every supervised analysis uses nested cross-validation with feature selection confined to training folds, explicit batch-effect assessment, and, where feasible, an independent validation set or hold-out cohort before any biomarker or subtype claim is reported.

## Case Study

### Independent research example: AI-integrated proteomics, PTM, and metabolomics for schizophrenia risk

This publication is not a CD Genomics customer project.

**Background:** Schizophrenia is a heterogeneous psychiatric disorder whose molecular basis is poorly resolved by any single omics layer. The researchers asked whether an automated machine learning framework integrating plasma proteomics, post-translational modification (PTM), and metabolomics data could identify a cross-layer molecular signature and outperform any single layer alone.

**Methods:** Hong et al. applied a multi-omics integration framework with automated machine learning to plasma samples from 104 individuals in an open-access cohort, comparing 17 machine learning models trained on the integrated feature set against models trained on each omics layer alone.

**Results:** Seven of 17 models achieved AUC values above 0.9000 using the integrated feature set. The top-performing integrated model, LightGBMXT, reached AUC 0.9727 (95% CI: 0.8889-1.000), outperforming the best single-omics model, CNNBiLSTM on proteomics alone, at AUC 0.9636 (95% CI: 0.8636-1.0000). Key discriminative features included carbamylation at immunoglobulin sites IGKC_K20 and IGHG1_K8, and oxidation of coagulation factor F10 at residue M8. Enriched pathways included complement activation, platelet signaling, and gut microbiota-associated metabolism, with coagulation factors F2, F10, and PLG and complement regulators CFI and C9 identified as central network hubs.

**Conclusion:** Integrating proteomics, PTM, and metabolomics data with an automated machine learning framework improved classification performance over any single omics layer and surfaced a mechanistically coherent, cross-validated molecular signature. Results from one study do not predict another project; sample size and cohort composition still bound what any integrated model can support.

Reference: Hong F, Chen Q, Luo X, et al. [A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification](https://doi.org/10.3390/ijms26157640). *International Journal of Molecular Sciences*. 2025;26(15):7640.

## Publications

1. Baião AR, Cai Z, Poulos RC, et al. [A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches](https://doi.org/10.1093/bib/bbaf355). *Briefings in Bioinformatics*. 2025;26(4):bbaf355.
2. Vahabi N, Michailidis G. [Unsupervised Multi-Omics Data Integration Methods: A Comprehensive Review](https://doi.org/10.3389/fgene.2022.854752). *Frontiers in Genetics*. 2022;13:854752.
3. Walsh I, Fishman D, Garcia-Gasulla D, et al. [DOME: recommendations for supervised machine learning validation in biology](https://doi.org/10.1038/s41592-021-01205-4). *Nature Methods*. 2021;18:1122-1127.
4. Yu Y, Mai Y, Zheng Y, Shi L. [Assessing and mitigating batch effects in large-scale omics studies](https://doi.org/10.1186/s13059-024-03401-9). *Genome Biology*. 2024;25:254.
5. Hong F, Chen Q, Luo X, et al. [A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification](https://doi.org/10.3390/ijms26157640). *International Journal of Molecular Sciences*. 2025;26(15):7640.